科学研究出版的参考

学术期刊

在线客服：
对外合作：

联系：400-6379-560
feedback@hanspub.org

客服号

人工客服，稿件咨询

公众号

科技成果分享

● C. Wich, A. Agaimy, D. Strobel, et al. Sustained treatment response of metastati...
● L. Rossi, F. Zoratto, A. Papa, et al. Current approach in the treatment of hepat...
● 张伟, 孙惠川, 熊宇泉等. 合用阿伐斯汀增强索拉非尼对肝癌生长转移的抑制作用[J]. 中华实验外科杂志, 2010, 27(2): 3.
● 万骋, 崔斐, 陈斌等. 抗肿瘤血管生成药bevacizumab对VEGF促人肝癌细胞株HepG2增殖的阻断作用[J]. 第二军医大学学报, 2008, 29(...
● 陈方国, 陈漪, 于观贞等. Bevacizumab抑制高转移性人肝癌原位移植瘤的血管形成[J]. 中国临床医学, 2006, 13(6): 2.
● 郭子姮, 王杰军, 于观贞等. Bevacizumab抑制高转移性人肝癌原位移植瘤的淋巴管形成[J]. 肿瘤, 2006, 26(8): 4.
● N. E. Kemeny, L. Schwartz, M. Gonen, et al. Treating primary liver cancer with h...
● Y. Q. Xiong, H. C. Sun, X. D. Zhu, et al. Bevacizumab enhances chemosensitivity ...
● D. Semela, A. C. Piguet, M. Kolev, K. Schmitter, R. Hlushchuk, V. Djonov, et al....
● L. C. Ong, I. C. Song, Y. Jin, et al. Effective inhibition of xenografts of hepa...
● C. H. Hsu, T. S. Yang, C. Hsu et al. Efficacy and tolerability of bevacizumab pl...
● A. B. Siegel, E. I. Cohen, A. Ocean et al. Phase II trial evaluating the clinica...
● N. Lassau, S. Koscielny, L. Chami et al. Advanced hepatocellular carcinoma: earl...
● A. X. Zhu, L. S. Blaszkowsky, D. P. Ryan, et al. Phase II study of gemcitabine a...
● R. K. Jain. Normalization of tumor vasculature: an emerging concept in antiangio...
● L. G. Presta, H. Chen, S. J. O’connor, et al. Humanization of an anti-vascular e...
● R. S. Warren, H. Yuan, M. R. Matli, et al. Regulation by vascular endothelial gr...
● K. J. Kim, B. Li, J. Winer, et al. Inhibition of vascular endothelial growth fac...
● P. Borgstrom, M. A. Bourdon, K. J. Hillan, P. Sriramarao, and N. Ferrara. Neutra...
● P. Borgstrom, K. J. Hillan, P. Sriramarao, and N. Ferrara. Complete inhibition o...
● O. Melnyk, M. A. Shuman, and K. J. Kim. Vascular endothelial growth factor promo...
● R. S. Warren, H. Yuan, M. R. Matli, N. A. Gillett, and N. Ferrara. Regulation by...
● O. N. El-Assal, A. Yamanoi, Y. Soda et al. Clinical significance of microvessel ...
● H. M. Sowter, A. N. Corps, A. L. Evans, D. E. Clark, D. S. Charnock-Jones, and S...
● M. Tomisawa, T. Tokunaga, Y. Oshika, T. Tsuchida, Y. Fukushima, H. Sato, H. Kiji...
● L. M. Ellis, Y. Takahashi, C. J. Fenoglio, K. R. Cleary, C. D. Bucana, and D. B....
● H. Yoshiji, D. E. Gomez, M. Shibuya, and U. P. Thorgeirsson. Expression of vascu...
● M. Volm, R. Koomagi, and J. Mattern. Prognostic value of vascular endothelial gr...
● L. Jussila, K. Alitalo. Vascular growth factors and lymphangiogenesis. Physiolog...
● Y. Ren, B. Cao, S. Law, et al. (2005) Hepatocyte growth factor promotes cancer c...

● C. Wich, A. Agaimy, D. Strobel, et al. Sustained treatment response of metastati...

● L. Rossi, F. Zoratto, A. Papa, et al. Current approach in the treatment of hepat...

● 张伟, 孙惠川, 熊宇泉等. 合用阿伐斯汀增强索拉非尼对肝癌生长转移的抑制作用[J]. 中华实验外科杂志, 2010, 27(2): 3.

● 万骋, 崔斐, 陈斌等. 抗肿瘤血管生成药bevacizumab对VEGF促人肝癌细胞株HepG2增殖的阻断作用[J]. 第二军医大学学报, 2008, 29(...

● 陈方国, 陈漪, 于观贞等. Bevacizumab抑制高转移性人肝癌原位移植瘤的血管形成[J]. 中国临床医学, 2006, 13(6): 2.

● 郭子姮, 王杰军, 于观贞等. Bevacizumab抑制高转移性人肝癌原位移植瘤的淋巴管形成[J]. 肿瘤, 2006, 26(8): 4.

● N. E. Kemeny, L. Schwartz, M. Gonen, et al. Treating primary liver cancer with h...

● Y. Q. Xiong, H. C. Sun, X. D. Zhu, et al. Bevacizumab enhances chemosensitivity ...

● D. Semela, A. C. Piguet, M. Kolev, K. Schmitter, R. Hlushchuk, V. Djonov, et al....

● L. C. Ong, I. C. Song, Y. Jin, et al. Effective inhibition of xenografts of hepa...

● C. H. Hsu, T. S. Yang, C. Hsu et al. Efficacy and tolerability of bevacizumab pl...

● A. B. Siegel, E. I. Cohen, A. Ocean et al. Phase II trial evaluating the clinica...